Mailforge provisions outbound sending domains and mailbox slots and automates the associated DNS configuration.
RevManicRevenue Stack
Part of Salesforge OÜ
Shared email infrastructure for cold-email outreach, providing domains, mailbox slots, automated DNS setup, and hosted mailbox maintenance.
Revenue footprint
Mailforge provisions outbound sending domains and mailbox slots and automates the associated DNS configuration.
Overview
Mailforge provides distributed, shared-IP email infrastructure designed for cold-email campaigns. Customers purchase domains and mailbox capacity, while Mailforge handles mailbox hosting, maintenance, and automated SPF, DKIM, and DMARC configuration.
Buying context
Pricing
Public calculator-based pricing in USD. Mailbox slots and domains are purchased separately; add-ons and consulting are separately priced. Taxes are excluded from displayed prices and calculated based on buyer location/details.
Annual add-on price is shown on the pricing page, but the exact page text is inconsistent about the displayed annual unit; verify in-app before purchase.
Check current price ↗Add-on priced per domain; the pricing page lists $2 per domain per month.
Check current price ↗Annual billing is discounted; the official page shows $3/month as the mailbox cost when billed yearly but does not publish the complete annual total or rate table.
Check current price ↗$3 per mailbox slot per month shown for monthly billing; minimum purchase is 10 slots.
Check current price ↗The calculator shows .com domains at $14 per domain per year, charged once. Other TLD pricing is not fully published.
Check current price ↗Two one-to-one consulting sessions.
Check current price ↗List prices can exclude tax, usage charges, onboarding, add-ons, and negotiated discounts. Check the vendor page before buying.
Reviews
RevManic has not ingested a verified review source for this product yet. We do not convert vendor testimonials into star ratings.
Suggest a review sourceWe reviewed these official vendor documents. Product claims have not yet been independently tested.